Financial News
Nanovibronix Inc (NQ: NAOV )
0.7370
-0.0180
(-2.38%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Jun 25, 2024
Add to My Watchlist
Press Releases about Nanovibronix Inc
![](https://mms.businesswire.com/media/20230118005140/en/1688215/22/Nano.v.2-56.jpg)
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
November 28, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Announces Interim Results of Clinical Study for UroShield
November 16, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Provides Business Update in Letter to Shareholders
November 15, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
October 19, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
September 23, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Sets Date for Annual Shareholder Meeting
September 14, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Provides Business Update in Letter to Shareholders
August 18, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Advances Efforts to Achieve NHS Approval
April 05, 2022
From NanoVibronix, Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From NanoVibronix Inc.
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
NanoVibronix Reports Third Quarter 2021 Financial Results
November 16, 2021
From NanoVibronix, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.